Sr One Capital Management, LP Portfolio Holdings
Sr One Capital Management, LP
- $279 Million
- Q2 2025
Sr One Capital Management, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $279 Million distributed in 13 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $155M, Crispr Therapeutics Ag with a value of $51M, Oric Pharmaceuticals, Inc. with a value of $45.8M, Design Therapeutics, Inc. with a value of $22M, and Nkarta, Inc. with a value of $5.53M.
Examining the 13F form we can see an increase of $57.9M in the current position value, from $221M to 279M.
Below you can find more details about Sr One Capital Management, LP portfolio as well as his latest detailed transactions.